Table 3 Distribution of patients relative to the SWAS and comparison of CPM and no-CPM groups
SWAS | CPM group | No-CPM group | P value |
|---|---|---|---|
Swelling | 0.157 | ||
0 | 27 (26.5%) | 17 (15.8%) | |
1 | 57 (55.9%) | 70 (64.8%) | |
2 | 18 (17.6%) | 21 (19.4%) | |
Erythema | 0.463 | ||
0 | 95 (93.1%) | 97 (89.8%) | |
1 | 7 (6.9%) | 11 (10.2%) | |
2 | 0 | 0 | |
Hematoma | 0.028 | ||
0 | 58 (56.9%) | 44 (40.8%) | |
1 | 36 (35.3%) | 46 (42.6%) | |
2 | 8 (7.8%) | 18 (16.6%) | |
Drainage | 0.558 | ||
0 | 68 (66.7%) | 73 (67.6%) | |
1 | 28 (27.5%) | 25 (23.2%) | |
2 | 6 (5.9%) | 10 (9.2%) | |
Blisters | 0.175 | ||
0 | 98 (96.1%) | 98 (90.7%) | |
1 | 2 (2%) | 8 (7.4%) | |
2 | 2 (2%) | 2 (1.9%) | |
Total | 0.289 | ||
0 | 11 (10.8%) | 5 (4.6%) | |
1 | 36 (35.3%) | 29 (26.9%) | |
2 | 25 (24.5%) | 34 (31.5%) | |
3 | 12 (11.8%) | 16 (14.8%) | |
4 | 12 (11.8%) | 11 (10.2%) | |
5 | 3 (2.9%) | 7 (6.5%) | |
6 | 2 (2%) | 4 (3.7%) | |
7 | – | 2 (1.9%) | |
8 | 1 (1%) | – | |
9 | – | – | |
10 | – | – | |